ばいちょ(売価調査)、価格比較とネットでのお買い物を楽に

内容説明
Pneumonia - Osler’s ?Captain of the Men of Death? and still the leading infectious cause of death in the United States - has until now received scant attention from historians. In ?Pneumonia Before Antibiotics?， clinician-historian Scott H. Podolsky uses pneumonia’s enduring prevalence and centrality to the medical profession’s therapeutic self-identity to examine the evolution of therapeutics in twentieth-century America. Focusing largely on the treatment of pneumonia in the first half of the century with type-specific serotherapy， Podolsky provides unique insights into the rise and clinical evaluation of therapeutic ?specifics，? the contested domains of private practice and public health， and - as the treatment of pneumonia made the transition from serotherapy to chemotherapy and antibiotics - the tempo and mode of therapeutic change itself. Type-specific serotherapy， founded on the tenets of applied immunology， justified by controlled clinical trials， and grounded in a novel public ethos， was deemed revolutionary when it emerged to replace supportive therapeutics. With the advent of the even more revolutionary sulfa drugs and antibiotics， pneumonia ceased to be a public health concern and became instead an illness treated in individual patients by individual physicians. Here Podolsky focuses on the new therapeutics and the scientists and practitioners who developed and debated them. He finds that， rather than representing a barren era in anticipation of some unknown transformation to come， the first decades of twentieth-century American medicine shaped the use of， and reliance upon， the therapeutic specific throughout the twentieth century and beyond. This intriguing study will interest historians of medicine and science， policymakers， and clinicians alike.